SGO
SGO
Topics
  • Daily Coverage
  • Photo Gallery
  • Meeting Program
  • Registration
  • Archive
Facebook iconInstagram iconTwitter X icon LinkedIn icon
  • Daily Coverage
  • Photo Gallery
  • Meeting Program
  • Registration
  • Archive
Topics
  • Daily Coverage
  • Photo Gallery
  • Meeting Program
  • Registration
  • Archive
Facebook iconInstagram iconTwitter X icon LinkedIn icon

SGO 2025

Sgo26 Awards Donor Appreciationand Research
SGO 2025
2026 Research Awards and Donor Appreciation
Apr 1st, 2026
Karen Lu, MD
SGO 2025
Get to Know SGO’s Incoming President
Mar 17th, 2025
audience shot
SGO 2025
A Potential New Detection Tool for Invasive Cervical Cancer
Mar 16th, 2025
Ginger Gardner, MD, FACOG
SGO 2025
Empowering Progress: The Foundation for Women's Cancer
Mar 16th, 2025
headshot of Dr. Choi
Archive
A Potential Second-Line Treatment for Cervical Cancer
Mar 15th, 2025
Tamar Gootzen, MD
SGO 2025
An Alternative Approach to Preventing Ovarian Cancer?
The ongoing TUBA-WISP II study could point the way to a new preventive approach for those at high risk for tubo-ovarian cancer.
Mar 15th, 2025
Fang Jiang, MD, PhD
Archive
Changing the Course for First-Line, Low-Risk Gestational Trophoblastic Neoplasia
Study marks first substantial cohort enrollment and analysis of this nature.
Mar 15th, 2025
Explore our DXd ADC Technology
Sponsored
Explore our DXd ADC Technology
At Daiichi Sankyo, we aim to expand the potential of antibody drug conjugates (ADCs) through our proprietary technology.
Mar 31st, 2026
Angela Nolin, MD
SGO 2025
It’s Time to Change the Diagnosis Protocol for Endometrial Cancer
Study finds that patients in certain ethnic groups aren’t always getting the timely diagnosis they need.
Mar 15th, 2025
Matthew A. Powell, MD
SGO 2025
Tricky But Treatable
Pembrolizumab alone and with olaparib offer winning combination in treatment of advanced ovarian cancer.
Mar 15th, 2025
Kathleen N. Moore, MD
Archive
Durvalumab Plus Carboplatin and Paclitaxel Delivers One-Two Punch for Endometrial Cancer Treatment
Trial evaluates frequency of different biomarkers and distribution of histological subtypes.
Mar 14th, 2025
Linda Duska, MD, MPH
Archive
Pembrolizumab Plus Chemotherapy Regimen Yields Clinically Positive Outcomes for Treatment of Locally Advanced Cervical Cancer
New approach confirms the effectiveness of a new standard of care.
Mar 14th, 2025
Welcome video
SGO 2025
Watch: Welcome to Seattle
We are glad you are here to multiply your impact.
Mar 14th, 2025
headshots of the program chairs
SGO 2025
Masterclasses and Hands-On Learning Set the Pace for SGO 2025
The SGO 2025 Annual Meeting on Women’s Cancer® offers groundbreaking research, interactive discussions, and networking opportunities.
Mar 14th, 2025
Amanda Nickles Fader, MD
SGO 2025
Q&A With SGO President Amanda Nickles Fader, MD
SGO President offers SGO Meeting News an exclusive look at what to expect at this year’s annual meeting as well as what the future of the field may hold.
Mar 14th, 2025
convention attendee using an iPad
SGO 2025
Get the SGO 2025 Mobile App
Stay up to date on SGO 2025 session information.
Mar 12th, 2025
SGO 2025
Fund the Future. Honor a Legacy
Mar 6th, 2025
Schwarze headshot
Archive
Invited Speaker: Gretchen Schwarze
Mar 3rd, 2025
Monica Bertagnolli headshot
Archive
Invited Speaker: Monica Bertagnolli
Mar 3rd, 2025
headshot of Jonathan Perlin
Archive
Invited Speaker: Jonathan Perlin
Mar 3rd, 2025
Liz Wiseman headshot
Archive
Author Liz Wiseman to Speak at Presidential Session
Feb 28th, 2025
CC arch in Seattle
SGO 2025
Housing and Travel for SGO 2025 Annual Meeting on Women’s Cancer
Feb 27th, 2025
Fellows Lounge 2023
Archive
Visit the Fellows Lounge
Feb 27th, 2025
Headshot of the social media ambassadors
Archive
Join the Conversation
Feb 27th, 2025
SGO
Facebook iconInstagram iconTwitter X icon LinkedIn icon
© 2026 Ascend Media. All rights reserved.